Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176,071,838
-
Total 13F shares
-
925,075
-
Share change
-
+308,401
-
Total reported value
-
$5,374,000
-
Price per share
-
$5.81
-
Number of holders
-
17
-
Value change
-
+$2,503,596
-
Number of buys
-
12
-
Number of sells
-
4
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q4 2020
As of 31 Dec 2020,
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
925,075 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Equitable Holdings, Inc., GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, and Engineers Gate Manager LP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.